Literature DB >> 17803759

Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history.

P H Lysaker1, M P Salyers.   

Abstract

OBJECTIVE: Anxiety is commonly observed in schizophrenia, but its relationship with other features of illness is unclear.
METHOD: We examined correlations between measures of anxiety, positive and negative symptoms, hope, psychosocial function and trauma history among 128 participants with schizophrenia or schizoaffective disorder. Cluster analyses were conducted to determine whether we could detect a subgroup with severe anxiety.
RESULTS: Higher levels of anxiety were associated with greater hallucinations, withdrawal, depression, hopelessness, better insight and poorer function. Cluster analyses produced three groups according to anxiety level: subclinical anxiety (n = 37), moderate anxiety (n = 55) and severe anxiety (n = 36). anova revealed that the severe anxiety group had more severe hallucinations, poorer psychosocial function and less hope than either of the other two groups. Self-report of sexual trauma predicted higher levels of anxiety overall.
CONCLUSION: A subgroup of persons with severe anxiety may be identifiable in schizophrenia with a unique clinical profile.

Entities:  

Mesh:

Year:  2007        PMID: 17803759     DOI: 10.1111/j.1600-0447.2007.01067.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  39 in total

1.  Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia.

Authors:  Paul H Lysaker; Philip T Yanos; Jared Outcalt; David Roe
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-04

2.  Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia.

Authors:  Alexandre Seillier; Andrea Giuffrida
Journal:  Behav Pharmacol       Date:  2017-10       Impact factor: 2.293

3.  Associations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes.

Authors:  Laura A Bajor; Douglas Gunzler; Douglas Einstadter; Charles Thomas; Richard McCormick; Adam T Perzynski; Stephanie W Kanuch; Kristin A Cassidy; Neal V Dawson; Martha Sajatovic
Journal:  Int J Psychiatry Med       Date:  2015-06-09       Impact factor: 1.210

4.  The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis.

Authors:  C M Corcoran; D Kimhy; M A Parrilla-Escobar; V L Cressman; A D Stanford; J Thompson; S Ben David; A Crumbley; S Schobel; H Moore; D Malaspina
Journal:  Psychol Med       Date:  2010-05-06       Impact factor: 7.723

5.  Evidence for inhibited temperament as a transdiagnostic factor across mood and psychotic disorders.

Authors:  Brandee Feola; Kristan Armstrong; Elizabeth A Flook; Neil D Woodward; Stephan Heckers; Jennifer Urbano Blackford
Journal:  J Affect Disord       Date:  2020-05-23       Impact factor: 4.839

6.  Psychiatric symptoms and mental health court engagement.

Authors:  Kelli E Canada; Greg Markway; David Albright
Journal:  Psychol Crime Law       Date:  2016-04-13

7.  N-Acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats.

Authors:  Marisa Möller; Jan L Du Preez; Francois P Viljoen; Michael Berk; Brian H Harvey
Journal:  Metab Brain Dis       Date:  2013-09-03       Impact factor: 3.584

8.  The Role of Metacognitive Self-Reflectivity in Emotional Awareness and Subjective Indices of Recovery in Schizophrenia.

Authors:  Kelsey A Bonfils; Lauren Luther; Sunita George; Kelly D Buck; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2016-12       Impact factor: 2.254

9.  N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.

Authors:  Twanette Swanepoel; Marisa Möller; Brian Herbert Harvey
Journal:  Psychopharmacology (Berl)       Date:  2017-11-08       Impact factor: 4.530

10.  Lack of relationship between psychological denial and unawareness of illness in schizophrenia-spectrum disorders.

Authors:  Carrie L Kruck; Laura A Flashman; Robert M Roth; Nancy S Koven; Thomas W McAllister; Andrew J Saykin
Journal:  Psychiatry Res       Date:  2009-07-17       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.